
Mike Walker
Health & Life Sciences Digital-Strategy Leader | Former Microsoft Executive Director & Gartner Analyst
Mike Walker is a digital-strategy leader in health and life sciences who advises pharmaceutical companies and biotechs on supply-chain security, cybersecurity, and digital transformation. He served as executive director of global health-and-life-sciences digital strategy at Microsoft, where he led the company’s point of view on how pharma, med-tech, and biopharma organizations modernize using digital ecosystems, digital twins, AI, and related technologies, and he was previously an analyst at Gartner.
Walker appeared on Open Door Salon alongside Clinton West, president of the supply chain security practice at Aardwolf Global Solutions and a former CIA supply-chain-risk leader, for a conversation on defending the pharmaceutical supply chain against cyber and geopolitical threats.
Walker’s lens was the deep technological dependency beneath the industry. The health-and-life-sciences supply chain, he argued, ultimately rests on the energy supply chain, with about a fifth of the world’s oil moving through the Strait of Hormuz, and on the semiconductor supply chain that runs from chip manufacturing through the data centers powering modern med-tech.
On cybersecurity, Walker made the case for proactive defense over reaction. As artificial intelligence grows more capable, he argued, attacks will scale through automation, and parts of the world operate without the AI restrictions that bind the US and Europe. Architecting supply chains and defenses to anticipate those threats, rather than respond to them after the fact, is the work he sees ahead.
On Open Door Salon
“Cyberattacks and Closed Straits — Defending Pharma on Two Fronts”
Clinton West & Mike Walker · May 13, 2026
Episode page & show notes on Open Door Salon
In this episode
- Energy as the supply chain beneath all supply chains
- From chip manufacturing to the data center
- Proactive defense vs. reacting to attacks
- AI-scaled attacks and uneven global restrictions
- Modernizing brittle, legacy supply chains
- The digital-transformation lens on pharma security
- Advising pharma and biotech on cyber resilience
Topics
Watch on Open Door Salon
Open Door Salon brings life-sciences leaders into candid conversation. Every Monday, the week's takeaways land in your inbox.
Subscribe on Substack →